R-5780, an oral immuno-oncology drug designed to activate gut-regulated immune pathways, will now be evaluated in a phase 1 ...

Dear Eric: I’m pretty sure I should seek therapy. As a longtime first responder with probable PTSD, plus recent marital issues and the recent deaths of a number of close loved ones, I feel the need to ...

Marc Herstand has been on the forefront of a campaign to ban mental health professionals in Wisconsin from counseling clients ...

Dr. Sattva S. Neelapu discusses how the CAR-T therapy Yescarta impacts the quality of life of patients with R/R indolent non-Hodgkin lymphoma.

Regulatory submissions for subcutaneous Sarclisa are planned for 2025, with ongoing studies exploring its use in various ...

Couples often don't realize they have the power to learn simple tools to defuse conflict and listen deeply. Our conflict can ...

A purification ceremony in Bali is trending on TikTok. While some locals welcome the interest, others are concerned that ...

Caribou has initiated the GALLOP Phase 1 clinical trial, an open-label, multicenter clinical trial designed to evaluate a single infusion of CB-010 in adult patients with LN and ERL. CB-011, a ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

A panelist discusses how loncastuximab tesirine, an antibody-drug conjugate targeting CD19, shows promise in combination with ...

NDA submitted to U.S. FDA for CAPLYTA® as adjunctive treatment for major depressive disorder; if approved, CAPLYTA® has ...

Yesterday we attended a grandson’s birthday party, and he was sullen and pushed to leave early. He’s not speaking to me today ...